Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Lispro Low Mix vs Glargine on Mood in Type 2 Diabetes
NCT00191178Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin lispro in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Perceived mood symptoms. Started Aug 2003; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00191178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191178.